Impact of Geographical Variations on the Prevalence of Multidrug-Resistant Organisms in Japan.


Journal

Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704

Informations de publication

Date de publication:
24 Sep 2020
Historique:
pubmed: 1 5 2020
medline: 28 4 2021
entrez: 1 5 2020
Statut: ppublish

Résumé

Emergence and spread of multidrug-resistant organisms (MDRO) is an urgent social and public health problem. Here, we carried out an epidemiological survey to clarify the geographical characteristics and factors influencing the prevalence of MDRO. Data on the prevalence of MDRO in 47 prefectures in Japan were extracted from the Japanese Nosocomial Infection Surveillance, a nationwide database for infection control. Potential factors for MDRO were analyzed using data selected from the pharmacological, medical service, infection control, environmental, social, and food-related categories, based on the characteristics of each organism and the correlations between them and MDRO prevalence. Statistical data for potential factors were obtained from public domains. The use of antibiotics was found to be correlated with the prevalence of penicillin-resistant Streptococcus pneumoniae, 3rd-generation cephalosporin- and fluoroquinolone-resistant Escherichia coli, and methicillin-resistant Staphylococcus aureus. Negative correlation between the consumption of food such as kelp and fermented soybeans that facilitate the growth of lactic acid bacteria and the prevalence of 3rd-generation cephalosporin- and fluoroquinolone-resistant E. coli suggested an association between the intestinal microflora and MDRO colonization. In addition to the use of antibiotics, lifestyle, food culture, and social factors such as tobacco smoking, average atmospheric temperature, prevalence of three-generation households, ratio of elderly population, average duration of tourist stay, chicken and fermented soybean consumption, and the competency of healthcare services may also affect MDRO prevalence.

Identifiants

pubmed: 32350219
doi: 10.7883/yoken.JJID.2019.498
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

354-360

Auteurs

Norihiro Saito (N)

Department of Clinical Laboratory Medicine, Hirosaki University Graduate School of Medicine, Japan.
Clinical Laboratory, Hirosaki University Hospital, Japan.

Satoko Minakawa (S)

Clinical Laboratory, Hirosaki University Hospital, Japan.

Fumio Inoue (F)

Clinical Laboratory, Hirosaki University Hospital, Japan.

Masahiko Kimura (M)

Clinical Laboratory, Hirosaki University Hospital, Japan.

Shu Ogasawara (S)

Clinical Laboratory, Hirosaki University Hospital, Japan.

Hiroyuki Kayaba (H)

Department of Clinical Laboratory Medicine, Hirosaki University Graduate School of Medicine, Japan.
Clinical Laboratory, Hirosaki University Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH